Processa Pharmaceuticals (PCSA) Inventory Average (2013 - 2015)
Processa Pharmaceuticals' (PCSA) quarterly Inventory Average came in at $172357.0 in Q3 2015, down 15.31% YoY from $203514.0 in Q3 2014, and down 13.9% on a QoQ basis from $200179.5 in Q2 2015.
Processa Pharmaceuticals (PCSA) Inventory Average (2013 - 2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 3 years of Inventory Average data on file, last reported at $172357.0 in Q3 2015.
- Quarterly Inventory Average fell 15.31% year-over-year to $172357.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $172357.0 (down 15.31% YoY) and the FY2014 annual result came in at $223729.5, up 61.53% from the prior year.
- Inventory Average eased to $172357.0 in Q3 2015, from $200179.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $246018.0 in Q1 2014 to a low of $172357.0 in Q3 2015.
- A 3-year average of $210617.2 and a median of $208166.0 in 2015 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2014 — Inventory Average rose 0.41% — and 2015, when it fell 15.39%.
- Tracing PCSA's Inventory Average over 3 years: stood at $217628.5 in 2013, then retreated by 3.52% to $209977.0 in 2014, then dropped by 17.92% to $172357.0 in 2015.
- The last three Inventory Average figures came in at $172357.0 (Q3 2015), $200179.5 (Q2 2015), and $208166.0 (Q1 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 172,357.00 |
| Jun 30, 2015 | 200,179.50 |
| Mar 31, 2015 | 208,166.00 |
| Dec 31, 2014 | 209,977.00 |
| Sep 30, 2014 | 203,514.00 |
| Jun 30, 2014 | 235,028.50 |
| Mar 31, 2014 | 246,018.00 |
| Dec 31, 2013 | 217,628.50 |
| Sep 30, 2013 | 202,686.50 |